Arin Tactical Tail Risk ETF ATTR 深 滬
等待開盤 11-19 09:30:00 美东时间
90.035
+0.009
+0.01%
華盛通- 最 高90.055
- 今 開90.055
- 成交量 1800股
- 最 低 90.035
- 昨 收 90.0256
- 總市值 0
- 52周最高 90.5782
- 市盈率 靜 --
- 換手率 Infinity.00%
- 52周最低 89.93
- 委 比 0.00%
- 總股本 --
- 歷史最高 90.5782
- 量 比 0
- 振 幅 0.02%
- 歷史最低 89.93
- 每 手 1
- 風險率 0.22%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多诺和诺德股价暴涨 公司连发重磅消息 退出竞购获华尔街支持
①诺和诺德旗下实验性药物coramitug的Ⅱ期临床试验数据公布，前一天还发布司美格鲁肽对代谢相关脂肪性肝炎疗效的数据； ②上周末，诺和诺德退出竞购Metsera公司，市场解读为战略决策，旨在保持现金流和长期增长前景。
11-12 04:26
诺和诺德连发重磅消息：退出Metsera竞购、司美格鲁肽降低肝损伤、印度市场降价37%
①诺和诺德旗下实验性药物coramitug的Ⅱ期临床试验数据公布，前一天还发布司美格鲁肽对代谢相关脂肪性肝炎疗效的数据；②上周末，诺和诺德退出竞购Metser...
11-12 04:26
Reported Saturday, Alnylam Pharmaceuticals HELIOS-B Phase 3 Study Of AMVUTTRA Shows Vutrisiran Improved Cardiac Structure And Function In ATTR-CM Patients With Amyloid Regression And Preserved Kidney Function
− Analyses Presented at the American Heart Association Scientific Sessions 2025 Underscore Vutrisiran's Differentiated Profile –− Cardiovascular Magnetic Resonance (CMR) and Echocardiographic Analyses Demonstrate that
11-10 16:58
URBAN ONE, INC. REPORTS THIRD QUARTER 2025 RESULTS
SILVER SPRING, Md., Nov. 4, 2025 /PRNewswire/ -- Urban One, Inc. (NASDAQ: UONEK and UONE) today reported its results for the three months ended September 30, 2025. For the three months ended...
11-04 20:00
Simon® Reports Third Quarter 2025 Results
Increases Full Year 2025 Real Estate FFO per share guidance Raises quarterly dividend by 4.8% year-over-year to $2.20 per share Completes acquisition of remaining 12% interest in The Taubman...
11-04 05:05
Why Is Alnylam Pharmaceuticals Stock Trading Lower Thursday?
Alnylam stock fell after a strong Q3 with $2.90 EPS and $1.25 billion revenue, a subpoena disclosure, and raised 2025 sales guidance to $3.6 billion–$3.8 billion.
10-31 02:39
Alnylam shares are trading lower after the company disclosed it received a subpoena from the U.S. Attorney seeking documents related to government price reporting for AMVUTTRA, ONPATTRO OXLUMO And GIVLAARI.
Alnylam shares are trading lower after the company disclosed it received a subp...
10-30 20:17
Uncovering Potential: Alnylam Pharmaceuticals's Earnings Preview
Alnylam Pharmaceuticals (NASDAQ:ALNY) is gearing up to announce its quarterly e...
10-29 22:04
